Stay updated on TVB-2640 in NASH Clinical Trial
Sign up to get notified when there's something new on the TVB-2640 in NASH Clinical Trial page.

Latest updates to the TVB-2640 in NASH Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page has been updated to reflect the submission of results and has been revised to version 2.15.2.SummaryDifference0.2%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version of the study protocol for TVB-2640, specifically focusing on subjects with liver fibrosis stage F2-F3, while significant details about the study's design and inclusion/exclusion criteria have been removed.SummaryDifference22%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to TVB-2640 in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TVB-2640 in NASH Clinical Trial page.